Position in FULC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,589,306
+$2,171,838 QoQ
Shares Held
1,253,909
+297.8% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 154 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. FULC ranks #152 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in FULC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,589,306 | 1,253,909 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,417,468 | 315,185 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,164,555 | 102,967 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,770,643 | 301,157 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $930,210 | 135,205 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $207,128 | 71,920 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $363,742 | 77,392 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $287,859 | 80,633 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,181,416 | 190,551 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $686,929 | 72,768 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $203,734 | 30,183 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $49,535 | 11,157 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $104,804 | 31,759 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,208 | 424 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $27,583 | 3,789 | Shares | Sole | 2023-02-08 | |
| 2022-03-31 | $34,741 | 1,469 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,594 | 825 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $36,814 | 1,305 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,872 | 942 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $17,917 | 1,521 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,864 | 330 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $25,582 | 3,226 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $79,378 | 4,340 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $96,869 | 8,113 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||